Search

Author/Creator Shimizu, S.

4. 1601 The multicenter, prospective observational study of the 5-HT3 receptor antagonist and dexamethasone as prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in moderately emetic chemotherapy (MEC) for solid tumors. (September 2015)

Authors:
Sugita, K.; Matsui, R.; Suzuki, K.; Takiguchi, T.; Nishio, M.; Koike, T.; Hayashi, T.; Seto, T.; Kogure, Y.; Nogami, N.; Fujiwara, K.; Kaneda, H.; Harada, T.; Shimizu, S.; Kimura, M.; Kenmotsu, H.; Shimokawa, M.; Goto, K.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 1951 Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+ breast cancer (BC) patients. (September 2015)

Authors:
Bando, H.; Masuda, N.; Nakamura, R.; Kondo, N.; Kuroi, K.; Akiyoshi, S.; Ohtani, S.; Toshimi, T.; Inoue, K.; Yanagida, Y.; Ishiguro, H.; Shimizu, S.; Aogi, K.; Amano, S.; Ozaki, S.; Iguchi-Manaka, A.; Kasai, H.; Morita, S.; Kataoka, T.R.; Toi, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S316
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗